Answers are grounded in this paper and cite their sources.
Background Atrial fibrillation (AF) is a common treatable risk factor for stroke. Screening for paroxysmal AF in general practice is difficult, but biomarkers might help improve screening strategies.
No takes yet. Share an insight, caveat, or question.
Schmalstieg-Bahr et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: